SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Debt Instrument, Interest Rate, Stated Percentage
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Debt Instrument, Interest Rate, Stated Percentage of 10.00% as of 2022-08-31, per its 10-K/A filed 2024-09-04.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2024-09-04
- 2022-08-31: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
- 2022-08-01: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
- 2022-03-11: Debt Instrument, Interest Rate, Stated Percentage 6.00%.
- 2022-02-08: Debt Instrument, Interest Rate, Stated Percentage 6.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2022-08-31 | 10.00% 10-K/A · filed 2024-09-04 |
| 2022-08-01 | 10.00% 10-K · filed 2023-03-15 |
| 2022-03-11 | 6.00% 10-K · filed 2023-03-15 |
| 2022-02-08 | 6.00% 10-K · filed 2023-03-15 |
| 2021-12-28 | 10.00% 10-K/A · filed 2024-09-04 |
| 2021-03-09 | 1.00% 10-K/A · filed 2024-09-04 |
| 2020-05-15 | 1.00% 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |